Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 112 participants.

Also called NCT01475799

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 112 participants (enrolled count) (from the registry)
Sponsor
Direct Flow Medical, Inc. (from the registry)
Registry
  • NCT NCT01475799
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France, Germany, Italy, Luxembourg, United Kingdom (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01475799. Allocation not applicable; no masking; primary purpose treatment. Start 2011-11 (registry gives no type); primary completion 2014-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis
Condition
Aortic Valve Stenosis
Intervention (Device)
Replacement of the Aortic Stenotic Valve
Lead sponsor
Direct Flow Medical, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01475799
Content hash
cb15b3a6ad83cdaca3c2b22597b3ac0c6d0ea4bd7e0a246de6a129063c76e1fb